WO1995023973A3 - Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents - Google Patents

Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents Download PDF

Info

Publication number
WO1995023973A3
WO1995023973A3 PCT/US1995/002195 US9502195W WO9523973A3 WO 1995023973 A3 WO1995023973 A3 WO 1995023973A3 US 9502195 W US9502195 W US 9502195W WO 9523973 A3 WO9523973 A3 WO 9523973A3
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant protein
synthetic peptide
hiv
utilizing recombinant
immunoassay utilizing
Prior art date
Application number
PCT/US1995/002195
Other languages
French (fr)
Other versions
WO1995023973A2 (en
Inventor
James L Gallarda
Barbara L Stone
Douglas J Liu
Susan K Harrington
George J Dawson
Ping Wu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to EP95911077A priority Critical patent/EP0698214A1/en
Priority to AU18809/95A priority patent/AU1880995A/en
Priority to JP7522932A priority patent/JPH08510063A/en
Publication of WO1995023973A2 publication Critical patent/WO1995023973A2/en
Publication of WO1995023973A3 publication Critical patent/WO1995023973A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

An assay to simultaneously detect the presence of HIV-1 antibody and/or HIV-2 antibody in a test sample is disclosed. The analytes are captured on either the same or different solid phases, and the presence of the analytes is determined by detecting a signal generated by using a cocktail of synthetic and recombinant antigen-containing indicator reagents.
PCT/US1995/002195 1994-03-02 1995-02-21 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents WO1995023973A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP95911077A EP0698214A1 (en) 1994-03-02 1995-02-21 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
AU18809/95A AU1880995A (en) 1994-03-02 1995-02-21 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
JP7522932A JPH08510063A (en) 1994-03-02 1995-02-21 HIV immunoassay using recombinant protein and synthetic peptide reagents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20470394A 1994-03-02 1994-03-02
US08/204,703 1994-03-02

Publications (2)

Publication Number Publication Date
WO1995023973A2 WO1995023973A2 (en) 1995-09-08
WO1995023973A3 true WO1995023973A3 (en) 1995-09-28

Family

ID=22759076

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/002195 WO1995023973A2 (en) 1994-03-02 1995-02-21 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents

Country Status (5)

Country Link
EP (1) EP0698214A1 (en)
JP (1) JPH08510063A (en)
AU (1) AU1880995A (en)
CA (1) CA2161872A1 (en)
WO (1) WO1995023973A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020122A (en) * 1995-06-07 2000-02-01 Abbott Laboratories Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system
US5922533A (en) * 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
US6846905B2 (en) * 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
EP1091976A2 (en) * 1998-07-02 2001-04-18 Peptide Solutions, Inc. Peptides from varicella-zoster and other viruses for hiv-2 diagnosis and therapy
JP3536731B2 (en) * 1999-07-28 2004-06-14 富士レビオ株式会社 HIV-1 p24 antigen immunoassay method and reagent
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
WO2002097333A2 (en) * 2001-05-25 2002-12-05 BSH Bosch und Siemens Hausgeräte GmbH Heat status display for a gas cooker point
FR2839555B1 (en) 2002-05-10 2007-07-27 Bio Rad Pasteur METHOD FOR THE SIMULTANEOUS DETECTION OF ANTIGEN AND ANTIBODY OF AN INFECTIOUS MICROORGANISM
EP4374790A3 (en) 2009-04-30 2024-07-31 DexCom, Inc. Performance reports associated with continuous sensor data from multiple analysis time periods
WO2013178737A1 (en) * 2012-05-30 2013-12-05 Bio-Rad Innovations Method for diagnosing and differentiating hiv-2 infections
US11709163B2 (en) 2014-10-08 2023-07-25 Avioq, Inc. Methods for simultaneous determination of serological profile and estimation of duration post HIV infection
SG10201505838PA (en) * 2015-07-27 2017-02-27 Mp Biomedicals Asia Pacific Pte Ltd Method and kit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000997A1 (en) * 1990-07-09 1992-01-23 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
WO1992001713A1 (en) * 1990-07-18 1992-02-06 Biochem Pharma Inc. Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses
WO1993009252A1 (en) * 1991-11-04 1993-05-13 Baxter Diagnostics Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
WO1993021346A1 (en) * 1992-04-09 1993-10-28 Abbott Laboratories Assay for detection of hiv antigen and hiv antibody

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000997A1 (en) * 1990-07-09 1992-01-23 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
WO1992001713A1 (en) * 1990-07-18 1992-02-06 Biochem Pharma Inc. Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses
WO1993009252A1 (en) * 1991-11-04 1993-05-13 Baxter Diagnostics Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
WO1993021346A1 (en) * 1992-04-09 1993-10-28 Abbott Laboratories Assay for detection of hiv antigen and hiv antibody

Also Published As

Publication number Publication date
WO1995023973A2 (en) 1995-09-08
CA2161872A1 (en) 1995-09-08
JPH08510063A (en) 1996-10-22
EP0698214A1 (en) 1996-02-28
AU1880995A (en) 1995-09-18

Similar Documents

Publication Publication Date Title
WO1999009410A3 (en) Rapid assay for simultaneous detection and differentiation of antibodies to hiv
DE69434285D1 (en) LYOPHILIZED LIGAND RECEPTOR COMPLEXES FOR DETECTION AND AS SENSORS
EP0154884A3 (en) Nucleic acid-protein conjugate
WO1995023973A3 (en) Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
ATE221997T1 (en) IMMUNOASSAYS FOR THE DETECTION OF ANTIPHOSPHOLIPIDE ANTIBODIES
TW370614B (en) Oligomerized antibodies, method of immunological determination using the same and reagent kit comprising the same
CA2285919A1 (en) Diagnostic tests and kits for clostridium difficile
ATE80735T1 (en) SOLID-SURFACE COLORIMETRIC IMMUNOESSAY, TEST ROD TO BE USED WITH IT AND ITS PREPARATION.
CA2188752A1 (en) Immunoassay for homocysteine
EP1475442A3 (en) Polypeptides of feline T-cell lymphotropic lentivirus
NZ231951A (en) Immunoassay for neutrophils (or fragments or soluble products of these) in milk for detecting mastitis and subclinical mastitis
CA2007336A1 (en) Diagnostic test using chimeric antibodies
EP1318401A3 (en) Method for the early detection of the seroconversion of an anti hepatitis C virus antibody
KR950008537A (en) Diagnostic Agents for Detection of Antibodies Against Epstein Bacillus (EBV)
CA2048655A1 (en) Discrimination between antibodies against htlv-1, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
CA2117378A1 (en) Htlv-i/htlv-ii assay and method
EP0346119A3 (en) Anti-fc assay for detection of antibodies
EP0806669A3 (en) Diagnostic reagent for hepatitis c virus infection
NZ334809A (en) Assay for the detection of antibodies against p53
EP0242589A3 (en) Detection of haptens in immunoassay techniques
EP0245052A3 (en) Detection of inflammation and novel antibodies therefor
IE870498L (en) Competitive elisa for detection of antibodies
ES2094124T3 (en) IMMUNOLOGICAL TEST OF ANTIBODIES AGAINST HIV.
CA2213083A1 (en) Detection of antibody production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2161872

Country of ref document: CA

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1995911077

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995911077

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995911077

Country of ref document: EP